Drug Side Effects
Search
HER2 NEGATIVE BREAST CANCER
HER2 NEGATIVE BREAST CANCER
was reported 51 times
These drug classes are most commonly taken by patients reporting HER2 NEGATIVE BREAST CANCER:
#
Drug
Count
0
Aromatase Inhibitor [EPC]
17
1
Estrogen Receptor Antagonist [EPC]
8
2
HER2/neu Receptor Antagonist [EPC]
7
3
Microtubule Inhibitor [EPC]
5
4
Kinase Inhibitor [EPC]
4
5
RANK Ligand Inhibitor [EPC]
4
6
Estrogen [EPC]
3
7
Nucleoside Metabolic Inhibitor [EPC]
3
8
Platinum-based Drug [EPC]
3
9
mTOR Inhibitor Immunosuppressant [EPC]
2
10
CD20-directed Cytolytic Antibody [EPC]
1
11
Interleukin-17A Antagonist [EPC]
1
12
Leukocyte Growth Factor [EPC]
1
13
Macrolide Antimicrobial [EPC]
1
14
Thiazide Diuretic [EPC]
1
15
Tumor Necrosis Factor Blocker [EPC]
1
16
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
17
Vitamin B12 [EPC]
1
18
Vitamin C [EPC]
1
19
Vitamin D [EPC]
1